A novel biodegradable injectable chitosan hydrogel for overcoming postoperative trauma and combating multiple tumors.

• CS@BPNSs@CuNPs can help postoperative hemostasis (24.98 %) and catch residual cells. • The hydrogel generated high ROS for antibacterial (98.1 %) and anticancer (11.3 %). • The combination of hydrogel and aPD-L1 showed a synergistic therapeutic effect. • The biodegradable hydrogel could cross blood tumor barrier to treat glioblastoma. Wound bacterial infections and tumor recurrence are the main reasons for the poor prognosis after primary tumor resection. Here, we fabricated a novel therapeutic nanocomposite using chitosan (CS) hydrogel combined with black phosphate nanosheets (BPNSs) and in situ grown copper nanoparticles (CuNPs). The obtained hydrogel (CS@BPNSs@CuNPs), possessing a remarkable temperature-sensitive spongy-like state, offered 24.98 % blood clotting index. The released BPNSs@CuNPs could produce reactive oxygen species (ROS) to kill infected invasive bacteria (98.1 %) and inhibit local residual tumor cell regeneration (11.3 %). Moreover, by coupling the photothermal properties of BPNSs, the BPNSs@CuNPs showed 19.6 % penetration rate to cross the blood tumor barrier (BTB) for treating brain tumors. The hydrogel platform was further combined with aPD-L1-based immunotherapy to employ its synergetic therapeutic effect in the prevention of tumors. The in vivo studies showed that biodegradable hydrogel could hold a great potential as a novel strategy for improving postoperative therapy and multi-tumor treatments. [ABSTRACT FROM AUTHOR]